15 July 2015 - The European Medicines Agency (EMA) is launching a public register of parallel distribution notices [External link icon] , providing a more transparent and user-friendly access to information on centrally authorised medicines put on the market by means of parallel trade in the European Union (EU).

Parallel distribution means that a centrally authorised medicine on the market in one Member State is distributed to another Member State by a company independent of the marketing-authorisation holder. To be able to sell a medicine in other Member States, parallel distributors need to ensure that the packaging and labelling of the medicine is appropriate, e.g. that the label, box and package leaflet are up to date and available in the correct language.

For more details, go to: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/07/news_detail_002370.jsp&mid=WC0b01ac058004d5c1